安进公司 AMGN 深沪

等待开盘 02-07 09:30:00 美东时间

374.31

+6.510

+1.77%

华盛通

立即下载

最高376.9052
今开365.725
成交量 60.69万股
最低 318.21
昨收 367.80
总市值 2.00亿
52周最高 376.9052
市盈率 ^静 36.40
换手率 113.65%
52周最低 0.00
委比 -84.62%
总股本 0.01亿
历史最高 376.9052
量比 0.87
振幅 15.96%
历史最低 0.00
每手 1
风险率 21.53%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

Exploring Amgen's Earnings Expectations

Amgen (NASDAQ:AMGN) is preparing to release its quarterly earnings on Tuesday, ...

02-02 23:01
Amgen Reports MariTide Weight Loss Holds Up With Fewer Doses

Amgen says its MariTide obesity drug helped patients maintain weight loss for a second year, with good safety and fewer side effects.

01-15 01:36
Amgen Growth Story Isn't Tapped Out Yet, Says Goldman

Goldman Sachs reiterates Buy rating and $403 price target for Amgen due to strong portfolio execution and 6 key growth drivers.

01-14 01:38
Zenas BioPharma Touts Phase 3 Win, But Stock Crashes

Zenas BioPharma shares fall after Phase 3 obexelimab data in IgG4-RD showed a 56% flare risk reduction, as investors weigh competition from Amgen's FDA-approved Uplizna.

01-05 23:21
Verastem Ends Lung Cancer Trial, Reallocates Resources

The RAMP 203 trial in advanced KRAS G12C–mutated non-small cell lung cancer has been discontinued due to increased competition.

01-03 01:56
US Medicaid Program Will Hit Swiss Wallets Hard, Roche CEO Says

Roche CEO predicts higher drug costs in Switzerland due to U.S. government's deals with pharmaceutical companies.

2025-12-22 21:43
Takeda's Once-Daily Psoriasis Pill Hits Phase 3 Goals, Beats Amgen's Drug

Takeda reports positive Phase 3 data for psoriasis drug zasocitinib, beating placebo and Otezla, with rapid PASI responses and FDA filing plans.

2025-12-19 03:10
White House Readies Drug Price Deals With AbbVie, Novartis, Roche

AbbVie and other drugmakers may announce U.S. drug pricing deals on Friday as the White House pushes lower prices and Medicare payment reforms.

2025-12-18 23:14
安进公司（Amgen）股价在成交量激增之际触及盘中低点，最新下跌2.9%。

安进公司（Amgen）股价在成交量激增之际触及盘中低点，最新下跌2.9%。

2025-12-06 04:41
劲方医药董事长吕强：创业8年，明白了科学家做老板不能只想着过创新的瘾

吕强是科学家里走出的创业者。2008年回国后，吕强在多家国内知名药企担任过高管，但和许多海归科学家出身的创业者一样，他觉得没过足“创新瘾”。2017年8月，吕强...

2025-12-02 21:10

派息除权日	每股总股息	派息日期
2022-05-16	1.94	2022-06-08
2022-02-14	1.94	2022-03-08
2021-11-15	1.76	2021-12-08
2021-08-16	1.76	2021-09-08
2021-05-14	1.76	2021-06-08
2021-02-11	1.76	2021-03-08
2020-11-13	1.60	2020-12-08
2020-08-14	1.60	2020-09-08
2020-05-15	1.60	2020-06-08
2020-02-13	1.60	2020-03-06
2019-11-14	1.45	2019-12-06
2019-08-14	1.45	2019-09-06
2019-05-16	1.45	2019-06-07
2019-02-14	1.45	2019-03-08
2018-11-15	1.32	2018-12-07
2018-08-16	1.32	2018-09-07
2018-05-16	1.32	2018-06-08
2018-02-14	1.32	2018-03-08
2017-11-16	1.15	2017-12-08
2017-08-15	1.15	2017-09-08
2017-05-15	1.15	2017-06-08
2017-02-13	1.15	2017-03-08
2016-11-14	1.00	2016-12-08
2016-08-15	1.00	2016-09-08
2016-05-13	1.00	2016-06-08
2016-02-11	1.00	2016-03-08
2015-11-12	0.79	2015-12-07
2015-08-13	0.79	2015-09-08
2015-05-12	0.79	2015-06-05
2015-02-10	0.79	2015-03-06
2014-11-10	0.61	2014-12-05
2014-08-12	0.61	2014-09-05
2014-05-13	0.61	2014-06-06
2014-02-11	0.61	2014-03-07
2013-11-12	0.47	2013-12-06
2013-08-14	0.47	2013-09-06
2013-05-14	0.47	2013-06-07
2013-02-11	0.47	2013-03-07
2012-11-13	0.36	2012-12-07
2012-08-14	0.36	2012-09-07
2012-05-14	0.36	2012-06-07
2012-02-13	0.36	2012-03-07
2011-11-15	0.28	2011-12-08
2011-08-16	0.28	2011-09-08
1997-03-24	0.0008	1997-03-21

公司名称	安进公司
行业分类	生物科技
业务描述	安进主要从事人类创新药的探索、研发、生产和销售，致力于为患有严重疾病的患者发掘生物科技潜力。通过借助前沿人类遗传学等工具，力求揭示疾病的复杂性，为理解人体生物学的原理奠定基础。自从公司1980 年创始以来，安进已经成长为全球最大的领先生物科技公司之一，为全球数百万患者提供创新药物，同时拥有一批极具潜力的在研药物。

安进公司 AMGN 深 沪

374.31

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

安进公司 AMGN 深沪